UK shares: is this under-the-radar growth stock set to surge in 2025?

Shares in UK packaging firm Macfarlane don’t get much coverage. But cyclically low earnings combined with a depressed multiple has our author’s attention.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Businessman using pen drawing line for increasing arrow from 2024 to 2025

Image source: Getty Images

Shares in UK packaging firm Macfarlane Group (LSE:MACF) look very attractive to me. As far as I can tell, only three analysts cover the stock and I think the market is underestimating the firm’s prospects.

Earnings are currently depressed by what I believe are cyclical pressures, but the stock is trading at an unusually low multiple. As a result, the share price looks to me like a coiled spring.

What does MacFarlane do?

MacFarlane is a packaging company. It adds value for its customers by cutting down on waste, reducing breakage costs, and improving transport and storage efficiency.

Around 86% of total revenues come from its distribution division. As the UK’s largest packaging distributor, it benefits from economies of scale that help reduce costs. 

The other part of the business is manufacturing. This is a smaller part of group sales, but higher margins from a focus on bespoke packaging for high-value products mean it generates 26% of operating profits.

Acquisitions have been key to MacFarlane’s strategy. Since 2020, the firm has added 10 separate firms to its organisation, which accounts for a lot of its growth.

Discount pricing

Right now, Macfarlane shares trade at a price-to-earnings (P/E) multiple below 12, which is at the lower end of its 10-year range. But given the company’s recent performance, this isn’t entirely unjustified.

Macfarlane P/E ratio 2015-2024


Source: TradingView

The firm’s latest earnings report reported declines in both sales (8%) and profits (4%). And it would have been worse but for the effect of some recent acquisitions.

Manufacturing revenues were strong but lower prices and volumes on the distribution side resulted in overall sales falling. Management is largely attributing the weaker demand to cost-of-living pressures.

The risk for investors is that these prove persistent – and there’s not much Macfarlane can do about this. And if earnings keep falling, I see no reason to expect the P/E multiple to expand from its current level.

Investment thesis

Even accounting for ongoing inflation weighing on consumer demand, I think there’s a good chance earnings could move higher from their current levels. One reason for this is recent acquisition activity.

In its latest report, management noted its acquisition of Polyformes (completed in July) should boost earnings from the next update. I therefore expect to see strength in the manufacturing division.

Investors should also note that Macfarlane’s growth has been exceptionally strong during the last couple of years. As a result, earnings per share (EPS) have grown at an average of 8.5% over the last decade.

Macfarlane EPS growth 2020-2024


Created at TradingView

I think the company can get back to growing its earnings in 2025. And if it does, I can see clear scope for the stock to trade at a higher multiple, providing a strong return for investors.

My price target

If earnings per share get back to 10p (2022 levels), I think the stock could trade at a P/E multiple of 15 (the mid-point of the 10-year range). That implies a share price of £1.50, which is 39% above the current level.

I think this could happen in 2025. But even if it takes three years, investors could still do very well by owning the stock – even before factoring in a dividend with a current yield of 3.34%.

Stephen Wright has positions in Macfarlane Group Plc. The Motley Fool UK has recommended Macfarlane Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »